Elixinol Global Stock Analysis

Elixinol Pink Sheet Analysis Notes

About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.72. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elixinol Global recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. Elixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products under the Elixinol and Hemp Foods Australia brands in the Americas, Europe, and Australia. The company was incorporated in 2017 and is headquartered in Sydney, Australia. Elixinol Wellness operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Elixinol Global is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Elixinol Global call Paul Benhaim at 61 2 4044 4585 or check out https://www.elixinolwellness.com.

Elixinol Global Investment Alerts

Elixinol Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.5 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Elixinol Global's market, we take the total number of its shares issued and multiply it by Elixinol Global's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Elixinol Profitablity

The company has Profit Margin (PM) of (1.72) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.63.

Technical Drivers

As of the 2nd of May, Elixinol Global shows the Downside Deviation of 26.3, coefficient of variation of 673.36, and Mean Deviation of 31.34. Elixinol Global technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Elixinol Global, which can be compared to its peers. Please confirm Elixinol Global information ratio, as well as the relationship between the potential upside and kurtosis to decide if Elixinol Global is priced favorably, providing market reflects its regular price of 0.0053 per share. As Elixinol Global appears to be a penny stock we also advise to verify its total risk alpha numbers.

Elixinol Global Price Movement Analysis

Elixinol Global Predictive Daily Indicators

Elixinol Global Forecast Models

Elixinol Global's time-series forecasting models are one of many Elixinol Global's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elixinol Global's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Elixinol Global prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Elixinol shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Elixinol Global. By using and applying Elixinol Pink Sheet analysis, traders can create a robust methodology for identifying Elixinol entry and exit points for their positions.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Global. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

When running Elixinol Global's price analysis, check to measure Elixinol Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Global is operating at the current time. Most of Elixinol Global's value examination focuses on studying past and present price action to predict the probability of Elixinol Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Global's price. Additionally, you may evaluate how the addition of Elixinol Global to your portfolios can decrease your overall portfolio volatility.